Tenon Medical, Inc. (TNON)
NASDAQ: TNON · Real-Time Price · USD
1.840
-0.080 (-4.17%)
Dec 20, 2024, 4:00 PM EST - Market closed
Tenon Medical Stock Forecast
TNON's stock price has decreased by -83.21% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Tenon Medical stock have an average target of 16, with a low estimate of 8.00 and a high estimate of 24. The average target predicts an increase of 769.57% from the current stock price of 1.84.
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 15, 2024.
Analyst Ratings
The average analyst rating for Tenon Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 1 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Maxim Group | Maxim Group | Strong Buy Maintains $22 → $8 | Strong Buy | Maintains | $22 → $8 | +334.78% | Nov 15, 2024 |
Benchmark | Benchmark | Buy Reiterates $24 | Buy | Reiterates | $24 | +1,204.35% | Aug 14, 2024 |
Benchmark | Benchmark | Buy Maintains $40 → $24 | Buy | Maintains | $40 → $24 | +1,204.35% | Apr 15, 2024 |
Benchmark | Benchmark | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +25,986.96% | Mar 10, 2023 |
Benchmark | Benchmark | Buy Initiates $480 | Buy | Initiates | $480 | +25,986.96% | Jun 21, 2022 |
Financial Forecast
Revenue This Year
3.78M
from 2.93M
Increased by 29.03%
Revenue Next Year
7.57M
from 3.78M
Increased by 100.29%
EPS This Year
-16.88
from -68.64
EPS Next Year
-8.03
from -16.88
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | 4.2M | 9.5M | 9.5M |
Avg | 3.8M | 7.6M | 9.2M |
Low | 3.3M | 5.7M | 8.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | 43.4% | 150.1% | 25.5% |
Avg | 29.0% | 100.3% | 22.0% |
Low | 14.1% | 51.4% | 17.2% |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -12.15 | -5.46 | -6.92 |
Avg | -16.88 | -8.03 | -6.72 |
Low | -21.10 | -10.34 | -6.46 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.